Studies into the Possible Central Effects of the H–1 Receptor Antagonist, Fexofenadine

1]. The efficacy of fexofenadine in the treatment of seasonal allergic rhinitis has been demonstrated in double–blind placebo–controlled clinical trials [1]. However, there have been few studies on the central effects of fexofenadine [2], and therefore confirmation is required that it does not cause sedation, before recommendation can be made about its use by those involved in skilled activity." />

Stone BM, Turner C, Mills SL, Nicholson AN: Studies into the Possible Central Effects of the H-1 Receptor Antagonist, Fexofenadine. Int Arch Allergy Immunol 1999;118:338-338 (DOI: 10.1159/000024125) Free Abstract
Login (Subscriber / Returning Pay-per-View Customer)

New Pay-per View Customer
New Pay-per View Customer

Pay-per-View Options:

•  NEW: Payment on account
    With a Karger Pay-per-View account (down payment USD 100.00)
    you profit from a special rate for this and other single items.
    This item at the discounted price:                  USD 17.50
or
•  Direct payment
     This item at the regular price:                       USD 25.00

Search in this issue

This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.